New study tracks fluid and salt balance to improve low sodium treatment
NCT ID NCT05692726
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is observing 50 adults with low sodium levels (hyponatremia) who are receiving standard hospital treatment. Researchers will measure changes in blood and urine sodium, body water, and weight over the first five days. The goal is to better understand how the body balances fluids and electrolytes during treatment, which could lead to improved care in the future.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand how to treat low sodium levels, leading to safer and more effective treatment guidelines.
- What could go wrong
- This is a small observational study (50 people) that does not test a new treatment. It only measures what happens during standard care, so it cannot prove any new therapy works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2022
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with non-hypervolemic hyponatremia
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patients ≥ 18 years * Hypotonic hyponatremia * glucose-corrected plasma sodium \<130 mmol/l * serum osmolality \<280 mosmol/kg or lack of signs of non-hypotonic hyponatremia Exclusion Criteria: * Signs of extracellular volume expansion * Patients with liver cirrhosis and severe liver damage AST/ALT\>3xULN, AP\>6xULN, Bilirubin ≥ 3mg/dl * Patients with heart failure * Patients on dialysis and/or patients with oliguric renal impairment and plasma creatinine ≥ 3mg/dl * Patients after organ transplantation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Non-hypervolemic hyponatremia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Hospital of Cologne
RECRUITINGCologne, 50937, Germany